Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000556587 | SCV000659415 | likely benign | Adams-Oliver syndrome 5 | 2024-01-16 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170155 | SCV001332705 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-09-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001770494 | SCV001992351 | uncertain significance | not provided | 2023-04-19 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Ambry Genetics | RCV001170155 | SCV002752809 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2021-10-19 | criteria provided, single submitter | clinical testing | The p.R955H variant (also known as c.2864G>A), located in coding exon 18 of the NOTCH1 gene, results from a G to A substitution at nucleotide position 2864. The arginine at codon 955 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Ce |
RCV001770494 | SCV004162038 | uncertain significance | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | NOTCH1: PP2, BP4 |